<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Cancer drug design and discovery</title>
  </titleInfo>
  <name type="personal">
    <namePart>Neidle, Stephen</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">editor.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">ne</placeTerm>
    </place>
    <dateIssued encoding="marc">2014</dateIssued>
    <copyrightDate encoding="marc">2014</copyrightDate>
    <edition>2nd ed.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="gmd">electronic resource</form>
    <extent>1 online resource (673 pages) : illustrations</extent>
  </physicalDescription>
  <abstract>Cancer Drug Design and Discovery, Second Edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, DNA-targeted agents and more. This book includes several sections on the basic and applied science of cancer drug discovery and features those drugs that are now approved for human use and are in the marketplace, as well as those that are still under develo.</abstract>
  <tableOfContents>Part 1. Basic principles and methodology -- part II. Drugs in the laboratory and clinic -- part III. The reality of cancerdrugs in the clinic.</tableOfContents>
  <note type="statement of responsibility">Stephen Neidle, School of Pharmacy, University College London, UK.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Antineoplastic agents</topic>
    <topic>Design</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Cancer</topic>
    <topic>Chemotherapy</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>TECHNOLOGY &amp; ENGINEERING</topic>
    <topic>Technical &amp; Manufacturing Industries &amp; Trades</topic>
  </subject>
  <subject authority="fast">
    <topic>Antineoplastic agents</topic>
    <topic>Design</topic>
  </subject>
  <subject authority="fast">
    <topic>Cancer</topic>
    <topic>Chemotherapy</topic>
  </subject>
  <classification authority="lcc">RS431.A64 N45 2014eb</classification>
  <classification authority="ddc" edition="23">615.7/98</classification>
  <classification authority="ddc">673</classification>
  <identifier type="isbn">9780123972286</identifier>
  <identifier type="isbn">0123972280</identifier>
  <identifier type="isbn">9780123965219</identifier>
  <identifier type="isbn">0123965217</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="uri">http://www.sciencedirect.com/science/book/9780123965219</identifier>
  <location>
    <url displayLabel="ScienceDirect">http://www.sciencedirect.com/science/book/9780123965219</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">E7B</recordContentSource>
    <recordCreationDate encoding="marc">131014</recordCreationDate>
    <recordChangeDate encoding="iso8601">20190328114807.0</recordChangeDate>
    <recordIdentifier source="OCoLC">ocn868955791</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
